Oxygenta Pharmaceutical LimitedBSE: OXYGENTAPH

Oxygenta Pharmaceutical Limited Press Release Apr 21 2025

Apr 21, 2025 at 7:17 AM UTC · Issued by Oxygenta Pharmaceutical Limited

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sai Sudhakar Vankineni

View Attachment